PMID: 16505761Mar 1, 2006Paper

Acute hepatitis C in 2005

Gastroentérologie Clinique Et Biologique
Eric Nguyen-Khac

Abstract

There have been numerous new data in the field of acute hepatitis C in the past few years. The goal of this study was to gather recent results in the literature to determine the best current therapeutic strategy of acute hepatitis C. Epidemiology has made enormous progress with the disappearance of acute post transfusion hepatitis C. Infection by intravenous drug-addiction has became prevalent, and nosocomial and sexual modes of transmissions are now seen. At the same time, the average age of the infected patients has dropped by 13 years, and the proportion of acute forms with a spontaneously favourable outcome have increased compared to the period before 1995. Understanding of the predictive factors of cure have become important, particularly not to treat acute hepatitis C which will have a spontaneously favorable outcome. Waiting from 8 to 12 weeks after jaundice or symptomatic forms is recommended. The decision to treat must be made in the first 6 months, since the results are better compared to a late and longer treatment. Monotherapy by pegylated interferon for 6 months ensures more than 90% of sustained viral response. Shorter treatment is possible but high daily doses of interferon are necessary, reducing tolerance. Fina...Continue Reading

References

May 1, 1992·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·L ViladomiuJ Guardia
Jul 1, 1991·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J A QuirogaV Carreño
Jan 1, 1994·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·P LamperticoM Colombo
Apr 1, 1996·The Journal of Infectious Diseases·K KrawczynskiD A Carson
May 1, 1997·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·A ZibertM Roggendorf
Jul 22, 1998·Journal of Hepatology·P AmorosoL Sagliocca
Aug 19, 1999·The New England Journal of Medicine·M J AlterH S Margolis
Mar 8, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·G L ArmstrongH S Margolis
Feb 15, 2001·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J R OrlandS Cooper
Aug 2, 2001·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·L T YeungE A Roberts
Sep 27, 2002·The New England Journal of Medicine·Michael W FriedJian Yu
Dec 25, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Harald HoferPeter Ferenci
May 16, 2003·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·T SantantonioG Pastore
Jul 10, 2003·Gastroenterology·J Tilman GerlachGerd R Pape
Jul 10, 2003·Gastroenterology·Stuart C Gordon
Dec 3, 2003·Journal of Hepatology·Anna LicataCalogero Cammà
Jan 31, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Maria Antonietta CasiraghiAlessandro Remo Zanetti
May 4, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Heiner WedemeyerMichael P Manns
May 4, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Hideyuki NomuraSeizaburo Kashiwagi
Jun 2, 2004·Journal of Medical Virology·Marc LehmannHeiner Wedemeyer
Jun 9, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Sanaa M KamalMargaret James Koziel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.